Due to the special nature of medicines, returns and exchanges are not supported.
Final delivery from the nearest overseas warehous NEW


Cabozantinib (XL184) has a high disease control rate for a variety of advanced cancers and can shrink or even eliminate bone metastases. Cabozantinib (XL184) has broad-spectrum anti-cancer capabilities: kidney cancer, liver cancer, lung cancer, thyroid cancer, etc.